Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fluticasone propionate favoured for mild-to-moderate asthma

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Fluticasone propionate favoured for mild-to-moderate asthma. Pharmacoecon. Outcomes News 623, 5 (2011). https://doi.org/10.2165/00151234-201106230-00012

    Download citation

    Keywords

    • Nitric Oxide
    • Asthma
    • Fluticasone
    • Fluticasone Propionate
    • Montelukast